170505 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Assays involving receptors, cell surface antigens or cell surface determinants for cytokines; for lymphokines; for interferons
Sub-classes:REPORTER CELLS EXPRESSING CHIMERIC POLYPEPTIDES FOR USE IN DETERMINING PRESENCE AND OR ACTIVITY OF RECEPTORS ASSOCIATED WITH CANCER AND SELECTING TREATMENT
#2BIOMARKERS
#3PEPTIDE COMPOSITION AND USES THEREOF
#4EPHA2-TARGETING ANTIBODIES AND THEIR APPLICATIONS IN CANCER TREATMENT
#5SYSTEM AND METHODS FOR DIAGNOSING ACUTE INTERSTITIAL NEPHRITIS
#6PRECISION MEDICINE FOR TREATMENT OF KIDNEY FUNCTION DECLINE
#7TREATMENT OF SKIN DISEASES OR DISORDERS BY DELIVERY OF ANTI-OSMRBeta ANTIBODY
#8Coronavirus T Cell Epitopes, Megapools and Uses Thereof
#9MPL MUTATIONS IN JAK2 V617F NEGATIVE PATIENTS WITH MYELOPROLIFERATIVE DISEASE
#10SURROGATE CYTOKINE POLYPEPTIDES
#11Lung Cancer Prediction and Uses Thereof
#12EARLY DIAGNOSIS OF INFECTIONS
#13LIQUID BIOPSY YIELD ENHANCEMENT
#14METHOD FOR IDENTIFYING ANTI-CANCER AGENTS USING AN IN VITRO CELL CULTURE SYSTEM THAT MAINTAINS CANCER CELL STEMNESS
#15BIOMARKERS FOR DETECTING OF OUTCOME/RISK OF THE PATIENTS WITH A RESPIRATORY ILLNESS
#16METHODS FOR PROGNOSING AND PREVENTING METASTATIC LIVER DISEASE
#17FLT3-specific chimeric antigen receptors and methods using same
#18Early diagnosis of infections
#19PEPTIDE COMPOSITION AND USES THEREOF
#20Liquid biopsy yield enhancement
#21METHOD FOR PREDICTING THERAPEUTIC EFFECT OF BIOLOGICAL PREPARATION ON RHEUMATOID ARTHRITIS
#22Method for identifying anti-cancer agents using an in vitro cell culture system that maintains cancer cell stemness
#23MPL MUTATIONS IN JAK2 V617F NEGATIVE PATIENTS WITH MYELOPROLIFERATIVE DISEASE
#24KIT FOR DETECTING SUBSET OF HUMAN REGULATORY T CELL, AND DETECTION METHOD THEREOF
#25SYSTEM AND METHODS FOR DIAGNOSING ACUTE INTERSTITIAL NEPHRITIS
#26Plasmo photoelectronic immunosensor
#27FLT3-specific chimeric antigen receptors and methods using same
#28Method for monitoring cancer and for regulation of semaphorin 4D to improve cancer immunotherapy regimens
#29METHOD FOR PREDICTING THERAPEUTIC EFFECT OF BIOLOGICAL PREPARATION ON RHEUMATOID ARTHRITIS
#30Methods for prognosing and preventing metastatic liver disease
#31Method for identifying anti-cancer agents using an in vitro cell culture system that maintains cancer cell stemness
#32Biomarkers for determining the clinical response to cell therapy
#33Substituted purine compounds
#34MPL mutations in JAK2 V617F negative patients with myeloproliferative disease
#35PEPTIDE COMPOSITION AND USES THEREOF
#36Human monoclonal antibodies against CD25
#37Apparatus for screening cells
#38METHOD FOR PREDICTING THERAPEUTIC EFFECT OF BIOLOGICAL PREPARATION ON RHEUMATOID ARTHRITIS
#39Substituted purine compounds
#40Agents that modulate RGMb-neogenin-BMP signaling and methods of use thereof
#41Detection of acute myeloid leukaemia (AML) leukaemic stem cells (LSC)
#42Systems and methods for characterizing kidney diseases
#43Biological specimen evaluation methods using cytology and immunology
#44Method for the isolation for mammalian stem cells and uses thereof
#45Human monoclonal antibodies against CD25
#46Composition comprising material for inhibiting SCF or receptor thereof for treating or preventing diseases associated with vascular permeability
#47MPL mutations in JAK2 V617F negative patients with myeloproliferative disease
#48Human resistin receptor and use thereof
#49Compositions and methods for therapy and diagnosis of cancer and cancer metastasis
#50METHODS AND USES RELATING TO THE IDENTIFICATION OF COMPOUND INVOLVED IN PAIN AS WELL AS METHODS OF DIAGNOSING ALGESIA
#51ILCS BASED PATTERN RECOGNITION OF SEPSIS
#52MPL mutations in JAK2 V617F negative patients with myeloproliferative disease
#53Methods of treating hematological proliferative disorders by targeting EphA3 expressed on aberrant vasculature in bone marrow
#54CXC chemokine receptor 4 (CXCR4) antagonistic polypeptide
#55METHODS AND COMPOSITIONS FOR REGULATION OF NEUROLOGICAL CONDITIONS
#56BIOMARKERS AND ASSAYS FOR THE TREATMENT OF CANCER
#57Human monoclonal antibodies against CD25
#58Systems and methods for characterizing kidney diseases
#59HUMAN TUMOR NECROSIS FACTOR TR21 AND METHODS BASED THEREON
#60DIFFERENTIAL DIAGNOSTIC BIOMARKERS OF STROKE MIMICKING CONDITIONS AND METHODS OF USE THEREOF
#61Cells screening method
#62USE OF CXCR4 PROTEIN EXPRESSION ON THE SURFACE OF STEM CELLS AS A MARKER FOR TUMOR TROPIC POTENTIAL
#63EPHA3 ANTIBODIES FOR THE TREATMENT OF MULTIPLE MYELOMA
#64Methods for phenotyping of leukemias
#65COMPOSITIONS AND METHODS FOR INHIBITING ANGIOGENESIS AND TUMORIGENESIS
#66Heteroduplex tracking assay
#67CONSTRAINED HIV V3 LOOP PEPTIDES AS NOVEL IMMUNOGENS AND RECEPTOR ANTAGONISTS
#68REAGENTS THAT BIND CCX-CKR2
#69Assays And Kits For Determining HIV-1 Tropism
#70METHODS AND COMPOSITIONS FOR REGULATION OF NEUROLOGICAL CONDITIONS
#71IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS
#72Human Tumor Necrosis Factor TR21 and Methods Based Thereon
#73Uses of mammalian cytokines and agonists; related reagents
#74METHODS FOR TREATING AUTOIMMUNE DISORDERS
#75Antibodies to oncostatin M receptor
#76Compositions and Methods for Therapy and Diagnosis of Cancer and Cancer Metastasis
#77Method for detecting antigen specific or mitogen-activated T cells
#78INHIBITION OF EXTRACELLULAR SIGNAL-REGULATED KINASE 1/2 AS A TREATMENT FOR CARDIAC HYPERTROPHY AND HEART FAILURE
#79Pharmaceutical composition comprising cxcr3 inhibitor
#80Diagnosis and Therapy of Cell Proliferative Disorders Characterized by Resistance to Trail Induced Apoptosis
#81SYSTEMS AND METHODS FOR CHARACTERIZING KIDNEY DISEASE
#82Methods for identification of eicosapentaenoic acid analogs using anti-inflammatory receptors
#83Analysis of HIV-1 coreceptor use in the clinical care of HIV-1-infected patients
#84Human monoclonal antibodies against CD25
#85Heteroduplex tracking assay
#86ANALYSIS OF HIV-1 CORECEPTOR USE IN THE CLINICAL CARE OF HIV-1 INFECTED PATIENTS
#87METHOD FOR THE DIAGNOSIS AND/OR PROGNOSIS OF ALZHEIMER'S DISEASE
#88Human Mob-5 (IL-24) receptors and uses thereof
#89Cd4+ Cd25+ T-cells activated to a specific antigen
#90Use of Cxcr4 Protein Expression on the Surface of Stem Cells as a Marker for Tumor Tropic Potential
#91ANALYSIS OF HIV-1 CORECEPTOR USE IN THE CLINICAL CARE OF HIV-1-INFECTED PATIENTS
#92CD25+ DIFFERENTIAL MARKERS AND USES THEREOF
#93ILCS based pattern recognition of sepsis
#94Use of Eph Receptor Inhibitors for the Treatment of Neurodegenerative Diseases
#95Constrained Hiv V3 Loop Peptides as Novel Immunogens and Receptor Antagonists
#96Blockade of Elr+Cxc Chemokines as a Treatment For Inflammatory and Autoimmune Disease
#97Method for preventing HIV-1 infection of CD4 cells
#98Methods for identifying modulators of tumor necrosis factor receptors
#99Assay for Antibodies
#100Leptin antagonist and method for quantitative measurement of leptin
#101Analysis of HIV-1 coreceptor use in the clinical care of HIV-1-infected patients
#102Identification, isolation and elimination of cancer stem cells
#103Heteroduplex tracking assay
#104Systems and methods for identifying organ transplant risk
#105Prognosis and Systemic Therapy for Treating Malignancy
#106Antibodies against interleukin 17 receptor-like protein
#107Systems and methods for characterizing kidney diseases
#108Cell migration assay
#109Detecting and predicting pre-eclampsia
#110Immunotherapy for immune suppressed patients
#111Human G-protein chemokine receptor (CCR5) HDGNR10
#112Method for predicting the developmetn of allergic disease
#113Compositions and methods to diagnose and treat lung cancer
#114Nucleic acid encoding eosinophil eotaxin receptor
#115Method for detection of MIP-4 and CCRL2 binding and activity modulating agents
#116Predictive Methods For Cancer Chemotherapy
#117Assay for Antibodies
#118Human tumor necrosis factor TR21 and methods based thereon
#119Interleukin-8 homologous polypeptides and therapeutic uses thereof
#120Antibodies that bind CCX-CKR2
#121Method for identifying a substance which mediates interaction between interleukin 22 and an interleukin 22 receptor
#122Antagonist and agonist which bind to a strong binding site of chemokine receptor
#123Heteroduplex tracking assay
#124Interleukin-8 homologous polypeptides and therapeutic uses thereof
#125Eotaxin: eosinophil chemotactic cytokine
#126Methods for Treating Autoimmune Disorders
#127Antibodies to oncostatin M receptor
#128Potent, selective and non toxic c-kit inhibitors
#129Assay for antibodies
#130Method for preventing HIV-1 infection of CD4+ cells
#131Methods for identification and uses of anti-inflammatory receptors for eicosapentaenoic acid analogs
#132Human Mob-5 (IL-24) receptors and uses thereof
#133Methods of treatment with TR10 polypeptides
#134Methods and compositions for the identification, assessment, and therapy of small cell lung cancer
#135Cell migration assay
#136Interleukin 17 receptor-like protein
#137Eotaxin : eosinophil chemotactic cytokine
#138Cell proliferation associated with CCX CKR expression
#139Systems and methods for characterizing kidney diseases
#140Systems and methods for characterizing kidney diseases
#141Cellular virus receptors and methods of use
#142Interleukin-8 homologous polypeptides and therapeutic uses thereof
#143Novel complementing receptor-ligand pairs and adoptive immunotherapy using the same
#144Uses of mammalian cytokines and agonists; related reagents
#145Nucleic acid encoding eosinophil eotaxin receptor
#146Cell-based method and assay for measuring the infectivity and drug sensitivity of immunodeficiency virus
#147Oligonucleotides which inhibit expression of the OB-RGRP protein